Navigation Links
Cardium Announces Conference Call and Webcast to Review Recent Developments and Future Plans for the Excellarate(TM) Clinical Development Program
Date:5/12/2009

conference call will be available approximately one hour after the conclusion of the call by dialing 888-286-8010 (US) or 617-801-6888 using passcode 91941419. The webcast will be archived for 30 days.

About Cardium

Cardium Therapeutics, Inc. and its subsidiaries, InnerCool Therapies, Inc. and the Tissue Repair Company, are medical technology companies primarily focused on the development, manufacture and sale of innovative therapeutic products and devices for cardiovascular, ischemic and related indications.

Cardium's InnerCool Therapies subsidiary is a San Diego-based medical technology company in the emerging field of temperature modulation therapy to rapidly and controllably cool the body in order to reduce cell death and damage following acute ischemic events such as cardiac arrest or stroke, and to potentially lessen or prevent associated injuries such as adverse neurological outcomes. For more information about Cardium's InnerCool subsidiary and patient temperature modulation, including InnerCool's new RapidBlue(TM) System, which recently received FDA clearance, and its CoolBlue(TM) System, please visit www.innercool.com.

Cardium also has two biologic candidates in clinical development. Cardium's Tissue Repair Company subsidiary (TRC) is focused on the development of growth factor therapeutics for the treatment of severe chronic diabetic wounds. TRC's lead product candidate, Excellarate(TM), is a DNA-activated collagen gel for topical treatment formulated with an adenovector delivery carrier encoding human platelet-derived growth factor-B (PDGF-B). Excellarate(TM) is initially being developed to be administered once or twice for the potential treatment of non-healing diabetic foot ulcers. Other potential applications for TRC's Gene Activated Matrix(TM) (GAM) technology include therapeutic angiogenesis (cardiova
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Cardium Announces $5.3 Million Registered Direct Offering
2. Cardium Completes $5.3 Million Registered Direct Offering
3. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
4. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
5. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
6. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
7. Cardium Reports on First Quarter 2008 Highlights and Financial Results
8. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
9. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability
10. Cardium Launches New AWARE Clinical Study Website
11. Cardiums InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Avure Technologies celebrates a year of success and the one-year ... of high volume High Pressure Processing (HPP) systems. , “We’re ... PackExpo this year, which is where we first announced the ... CEO at Avure. “Sales of the new Avure machine are ... challenges of market demand for higher throughput. We sold our ...
(Date:10/30/2014)... challenges in the development of quantum technologies has been ... paper published today (28 October) in Nature Communications ... make a new type of flexibly designed microscopic trap ... sensors and specialised superfast computers, often depend on harnessing ... trapping these tiny particles are hugely problematic because of ...
(Date:10/27/2014)... TORONTO , Oct. 27, 2014 /PRNewswire/ ... GNBT) today announced two presentations demonstrating that the ... novel proprietary cancer immunotherapeutic AE37 vaccine correlated with ... The AE37 cancer vaccine is being developed by ... www.antigenexpress.com ). The presentations are being made at ...
(Date:10/27/2014)... The report “Smart Highway Market by ... Monitoring), and by Display (Variable Message Signs, Digital ... global market into various sub-segments with in-depth analysis ... drivers and restraints for this market with insights ... market tables and 37 figures spread through 141 ...
Breaking Biology Technology:In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 2In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 3Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 2Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 3Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 4Smart Highway Market by Technology, and Display Expected to Reach $27.992.0 Million by 2019- New Report by MarketsandMarkets 2Smart Highway Market by Technology, and Display Expected to Reach $27.992.0 Million by 2019- New Report by MarketsandMarkets 3Smart Highway Market by Technology, and Display Expected to Reach $27.992.0 Million by 2019- New Report by MarketsandMarkets 4
... PharmaNet Development Group, Inc., a leading provider of clinical development services to ... participation at several international professional meetings during the month of June. ... Drug Information Association (DIA) Annual Meeting, ... ...
... ... The use of codon optimization in gene synthesis has long been ... been awarded two US patents covering the technology. DNA2.0,s approach goes beyond ... gene optimization. The algorithm associated with this patent has been proven to ...
... the momentum of their previous events, the Stem Cell ... Stem Cell Awareness Rally in Denver, Colorado on June ... Florida, drew past and prospective patients, news media, U.S. ... public interested in learning more about stem cell treatment. ...
Cached Biology Technology:PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June 2DNA2.0 Awarded US Patents for Breakthrough Gene Optimization Technology -- Company's Unique Algorithm Enables Expression Yields up to 50 Times Greater than Competing Approaches 2DNA2.0 Awarded US Patents for Breakthrough Gene Optimization Technology -- Company's Unique Algorithm Enables Expression Yields up to 50 Times Greater than Competing Approaches 3Colorado Stem Cell Awareness Rally to Take Place in Denver, Colorado on June 13th, 2009 2Colorado Stem Cell Awareness Rally to Take Place in Denver, Colorado on June 13th, 2009 3
(Date:10/28/2014)... Europe and China have published a paper in the ... that reveals important details about key transitions in the ... and exotic algae, mosses, ferns, trees and flowers growing ... we eat and the ornamental plants adorning our homes, ... years of history., "Our study generated DNA sequences from ...
(Date:10/28/2014)... moving activity in a novel environment are linked ... to an experimental study completed at the University ... Fisheries Research Institute. The study used novel, long-term ... angling trials to analyse if behaviours predict the ... traditional and enriched hatchery rearing environments. Based ...
(Date:10/27/2014)... have delivered a scientific one-two punch with a pair ... via their sticky ends. , Collagen is the most ... and the fibrous tissues that support cells and hold ... synthetic collagen for tissue engineering and cosmetic and reconstructive ... been studying synthetic collagen for a decade, teasing out ...
Breaking Biology News(10 mins):New study uses DNA sequences to look back in time at key events in plant evolution 2New study uses DNA sequences to look back in time at key events in plant evolution 3Fish 'personality' linked to vulnerability to angling 2'Sticky' ends start synthetic collagen growth 2'Sticky' ends start synthetic collagen growth 3
... the subtext of a novel, the human genome sequence ... of A, C, T and G. Since DNA is ... genome sequences among individuals also holds clues to ancestry. ... sequence variations to diseases are very common nowadays. But ...
... - Discovery that a specific gene is integral to both ... toxin in the kernels may lead to ways to control ... the fungal gene ZFR1 and found that it is vital ... Production of the toxin decreased when the scientists disabled the ...
... 2008 -- Exposure to levels of radon gas typically found ... risk of developing lung cancer by as much as 60 ... issue of the journal Health Physics. The finding differs significantly ... of low-level radon exposure, which have detected a slightly elevated ...
Cached Biology News:Multi-institutional study identifies new form of inherited risk of cancer 2Defining gene's role may lead to prevention of dangerous corn toxin 2Defining gene's role may lead to prevention of dangerous corn toxin 3Exposure to low levels of radon appears to reduce the risk of lung cancer, new study finds 2Exposure to low levels of radon appears to reduce the risk of lung cancer, new study finds 3Exposure to low levels of radon appears to reduce the risk of lung cancer, new study finds 4
... station, 100-120 V, is used to coat the ... to create the source of the DNA that ... Helios gene gun. The station includes a tubing ... 12 foot Nalgene nitrogen regulator hose, two 0.1875 ...
... 220-240 V, is used for biolistic particle delivery ... an adjustable helium pulse to sweep DNA-, RNA-, ... wall of a small plastic cartridge directly into ... in situ, in vitro, in vivo, and ex ...
... system, 220-240 V, is used for biolistic ... handheld device employs an adjustable helium pulse ... gold microcarriers from the inner wall of ... cells. This system has a 2 square-centimeter ...
The Discovery Series PDQuest 2-D analysis software is used for imaging, analyzing, and databasing two-dimensional electrophoretic gels. The 10-user network license entitles ten users to access data f...
Biology Products: